Exact Sciences Corp (EXAS) Misses Q1 Expectations

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Exact Sciences Corp (EXAS) Misses Q1 Expectations

Exact Sciences (EXAS) Spec Buy Reiterated at Benchmark; Co. Anything But Revenue and Earnings Story

May 1, 2014 2:57 PM EDT

Benchmark maintained a Speculative Buy rating on Exact Sciences (NASDAQ: EXAS) with a price target of $25.00. Comments follow Q1 results.

"Revenues were $0.3 Million and EPS was ($0.23). That being said, Exact Sciences is anything but a revenue and earnings storyat least for now. The company made significant progress on two fronts. The publication of the results of the DEEP-C Study in the New England Journal of Medicine highlighted what the benefits of the... More